Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

NYSCF is developing new stem cell therapy to treat age-related macular degeneration

The New York Stem Cell Foundation (NYSCF) today announced that they are developing a stem cell therapy to treat patients suffering from age-related macular degeneration (AMD).

22 Mar 2021

In America, Covid vaccine eligibility is a ‘crazy quilt’ of state rules

In North Carolina, the nation's leading tobacco producer, any adult who has smoked more than 100 cigarettes in their lifetime can now be vaccinated against Covid.

22 Mar 2021

Blocking folate metabolism could reduce SARS-CoV-2 viral replication in infected cells

The novel beta-coronavirus virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and coronaviruses, in general, alter the host's cellular metabolism to support massive production of ~30 kB viral genomes and subgenomic viral RNAs. However, how this is achieved is largely unknown.

21 Mar 2021

The case for donating US Covid vaccines overseas

A Senate committee grilled federal officials about the shortage of vaccines to protect Americans against a pandemic virus. Two months later, the U.S. public had lost interest in the virus, and millions of vaccines were sitting in warehouses — although poor countries still needed them.

19 Mar 2021

N-terminal domain antibodies play a key role in COVID immunity

Scientists are learning that a lesser-studied region on the pandemic coronavirus is recognized by COVID-19 infection-fighting antibodies. These antibodies were identified in blood samples from previously infected patients, and were found to potently prevent the virus from infecting cells.

19 Mar 2021

Fighting SARS-CoV-2 with materials science

In a recent editorial in the journal Emergent Materials, Dr. Huseyin C. Yalcin from Qatar University Biomedical Research Center and Dr. Ajeet Kaushik from Florida Polytechnic University announce several important developments in their timely special issue entitled “Materials Science in the Battle against COVID-19”.

18 Mar 2021

Novel cancer-fighting gene therapy enters phase I clinical trial

Researchers from the MDC and Charité have developed a new gene therapy based around a special T-cell receptor that helps the immune system effectively recognize and fight cancer cells.

18 Mar 2021

Aptamer Group and Mologic enter commercial partnership to develop aptamer-based SARS-CoV-2 rapid antigen test

Aptamer Group, the developer of diagnostic and therapeutic Optimer™ reagents, today announced a commercial partnership with Mologic.

From Aptamer Group 18 Mar 2021

GMP-Ready Helper Plasmids for AAV Production

Manufactured in dedicated clean-rooms with mandated changeovers before new production cycles - AMSBIO introduces new pHelper-Kan plasmid DNA optimized for Adeno-Associated Virus (AAV) manufacturing.

18 Mar 2021

Researchers test cutting-edge 3D scanners to help improve prosthetic limb design

Cutting-edge 3D scanners have been put to the test by researchers from the University of Southampton and partners Exceed Worldwide to help increase the quality and quantity of prosthetics services around the world.

17 Mar 2021

Axol Bioscience and Censo Biotechnologies Announce Merger

Axol Bioscience Ltd and CENSO Biotechnologies today announced that the two companies have signed a merger agreement.

From Axol Bioscience Ltd 17 Mar 2021

New strategy may change the course of evolving COVID-19 pandemic

Launched in April 2020 by the World Health Organization (WHO), European Commission, France and The Bill & Melinda Gates Foundation, the ACT Accelerator is a partnership of leading public health agencies with equity at its heart.

16 Mar 2021

Engineered mouse Intestine Chip platform can help study host-microbiome interactions

Trillions of commensal microbes live on the mucosal and epidermal surfaces of the body and it is firmly established that this microbiome affects its host's tolerance and sensitivity of the host to a variety of pathogens.

16 Mar 2021

Novel computer-guided design tool helps increase the efficiency of cell conversions

There is a great need to generate various types of cells for use in new therapies to replace tissues that are lost due to disease or injuries, or for studies outside the human body to improve our understanding of how organs and tissues function in health and disease.

13 Mar 2021

Study addresses glycosylation concerns in SARS-CoV-2 vaccine design

An international team of researchers has found that glycosylation patterns are conserved across the native spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – and the recombinant spike proteins made in laboratories for use in vaccines.

11 Mar 2021

Promega launches XpressAmp™ Direct Amplification Reagents

Promega Corporation has released XpressAmp™ Direct Amplification Reagents that facilitate RNA extraction-free sample preparation that is automation-friendly.

From Promega Corporation 11 Mar 2021

Organ-on-chip consortium receives huge grant to develop a universal standard for pharmaceutical industry

Scientists are pushing ahead building 'organ-on-chips', small chips with human cells, which are useful, for example, for studying cancerous metastases in the bloodstream or the development of scar tissue, or for testing the effect of drugs or food outside a human body.

10 Mar 2021

Pfizer’s newest vaccine plant has persistent mold issues, history of recalls

Pfizer's management knew last year there was "a mold issue" at the Kansas facility now slated to produce the drugmaker's urgently needed covid-19 vaccine, according to a Food and Drug Administration inspection report.

10 Mar 2021

New SARS-CoV-2 vaccine candidate produces strong immune response, prevents SARS-CoV-2 infection

A new SARS-CoV-2 vaccine candidate, developed by giving a key protein's gene a ride into the body while encased in a measles vaccine, has been shown to produce a strong immune response and prevent SARS-CoV-2 infection and lung disease in multiple animal studies.

10 Mar 2021

Advanced 3D models and a telemedicine system enable online training in endoscopic sinus surgery

The world's first international online training session utilizing advanced 3D sinus models and a telemedicine system has taken place, highlighting a new mode of medical training in the Covid-19 era.

9 Mar 2021

Manufacturing News and Research

Further Reading

NYSCF is developing new stem cell therapy to treat age-related macular degeneration

In America, Covid vaccine eligibility is a ‘crazy quilt’ of state rules

Blocking folate metabolism could reduce SARS-CoV-2 viral replication in infected cells

The case for donating US Covid vaccines overseas

N-terminal domain antibodies play a key role in COVID immunity

Fighting SARS-CoV-2 with materials science

Novel cancer-fighting gene therapy enters phase I clinical trial

Aptamer Group and Mologic enter commercial partnership to develop aptamer-based SARS-CoV-2 rapid antigen test

GMP-Ready Helper Plasmids for AAV Production

Researchers test cutting-edge 3D scanners to help improve prosthetic limb design

Axol Bioscience and Censo Biotechnologies Announce Merger

New strategy may change the course of evolving COVID-19 pandemic

Engineered mouse Intestine Chip platform can help study host-microbiome interactions

Novel computer-guided design tool helps increase the efficiency of cell conversions

Study addresses glycosylation concerns in SARS-CoV-2 vaccine design

Promega launches XpressAmp™ Direct Amplification Reagents

Organ-on-chip consortium receives huge grant to develop a universal standard for pharmaceutical industry

Pfizer’s newest vaccine plant has persistent mold issues, history of recalls

New SARS-CoV-2 vaccine candidate produces strong immune response, prevents SARS-CoV-2 infection

Advanced 3D models and a telemedicine system enable online training in endoscopic sinus surgery

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®